287 related articles for article (PubMed ID: 35462897)
1. Proprietary Medicines Containing
Li QF; Lu WT; Zhang Q; Zhao YD; Wu CY; Zhou HF
Front Pharmacol; 2022; 13():773537. PubMed ID: 35462897
[No Abstract] [Full Text] [Related]
2. Chinese herbal medicines for the treatment of depression: a systematic review and network meta-analysis.
Dang C; Wang Q; Li Q; Xiong Y; Lu Y
Front Pharmacol; 2024; 15():1295564. PubMed ID: 38633609
[No Abstract] [Full Text] [Related]
3. The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: integrated meta-analysis and network pharmacology analysis.
Zhao Y; Xu D; Wang J; Zhou D; Liu A; Sun Y; Yuan Y; Li J; Guo W
Front Pharmacol; 2023; 14():1257617. PubMed ID: 37808199
[No Abstract] [Full Text] [Related]
4. [Network Meta-analysis of Chinese patent medicines in treatment of liver stagnation and spleen deficiency of depression].
Yu Y; Zhang G; Han T; Li J; Huang HL
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(23):5217-5224. PubMed ID: 32237360
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Chinese patent medicines combined with antidepressants for treatment of depression in adults: A multiple-treatment meta-analysis.
Yi L; Chen J; Li S; Cui W; Li J; Peng L; Peng C
J Psychiatr Res; 2024 Jun; 176():205-212. PubMed ID: 38878648
[TBL] [Abstract][Full Text] [Related]
6. Integrated network pharmacology and metabolomics to dissect the combination mechanisms of Bupleurum chinense DC-Paeonia lactiflora Pall herb pair for treating depression.
Li X; Qin XM; Tian JS; Gao XX; Du GH; Zhou YZ
J Ethnopharmacol; 2021 Jan; 264():113281. PubMed ID: 32810624
[TBL] [Abstract][Full Text] [Related]
7. Managing Depression with
Yang L; Shergis JL; Di YM; Zhang AL; Lu C; Guo X; Fang Z; Xue CC; Li Y
J Altern Complement Med; 2020 Jan; 26(1):8-24. PubMed ID: 31328996
[No Abstract] [Full Text] [Related]
8. Identification of Potential Biomarkers of Depression and Network Pharmacology Approach to Investigate the Mechanism of Key Genes and Therapeutic Traditional Chinese Medicine in the Treatment of Depression.
Shi Y; Chen D; Ma S; Xu H; Deng L
Evid Based Complement Alternat Med; 2021; 2021():2165632. PubMed ID: 35003290
[TBL] [Abstract][Full Text] [Related]
9. A network pharmacology and molecular docking approach to reveal the mechanism of Chaihu Anxin Capsule in depression.
Yang L; Zhao Y; Qu R; Fu Y; Zhou C; Yu J
Front Endocrinol (Lausanne); 2023; 14():1256045. PubMed ID: 37745719
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics analysis of the antidepressant prescription Danzhi Xiaoyao Powder in a rat model of Chronic Unpredictable Mild Stress (CUMS).
Zhu YL; Li SL; Zhu CY; Wang W; Zuo WF; Qiu XJ
J Ethnopharmacol; 2020 Oct; 260():112832. PubMed ID: 32387465
[TBL] [Abstract][Full Text] [Related]
11. Herbal medicine as adjunctive therapy with antidepressants for post-stroke depression: a systematic review and network meta-analysis of randomized controlled trials.
Zhang J; Ming S; Chen X; Zhang T; Qian H; Peng S; Ding Y
Front Pharmacol; 2023; 14():1180071. PubMed ID: 37521479
[No Abstract] [Full Text] [Related]
12. Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach.
Rao Y; Wang Y; Lin Z; Zhang X; Ding X; Yang Y; Liu Z; Zhang B
Front Cardiovasc Med; 2023; 10():1126110. PubMed ID: 37168657
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets and mechanisms of
Wang YJ; Wang YL; Jiang XF; Li JE
World J Diabetes; 2023 Nov; 14(11):1659-1671. PubMed ID: 38077804
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy evaluation and potential mechanism prediction on Pudilan Xiaoyan oral liquid in treatment of mumps in children based on meta-analysis, network pharmacology, and molecular docking.
Liu Y; Cui X; Xi J; Xie Y
Front Pharmacol; 2022; 13():956219. PubMed ID: 36210814
[No Abstract] [Full Text] [Related]
15. The pharmacological actions of Danzhi-xiaoyao-San on depression involve lysophosphatidic acid and microbiota-gut-brain axis: novel insights from a systems pharmacology analysis of a double-blind, randomized, placebo-controlled clinical trial.
Zhu X; Wu S; Zhou Y; Xiao T; Xia L; Wang Y; Xiao A; Guo J; Zhang M; Wen Y; Shang D; Yu L
J Biomol Struct Dyn; 2023 Aug; ():1-16. PubMed ID: 37632305
[TBL] [Abstract][Full Text] [Related]
16. [Exploration on mechanisms of Xiaoyao Powder in treating atherosclerosis and depressive disorder with concept of "treating different diseases with same method" based on network pharmacology].
Ming-Tai C; Jiao X; Hai-Dan L; Ying LI; Mei-Huan LI; Jie-Nan L; Zhong Z
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4099-4111. PubMed ID: 33164394
[TBL] [Abstract][Full Text] [Related]
17. Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis.
Lin A; Zhang Z; Liu X; Wu J
Heliyon; 2023 Aug; 9(8):e18711. PubMed ID: 37593598
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Chaihu Jia Longgu Muli Decoction in the Treatment of Poststroke Depression: A Systematic Review and Meta-Analysis.
Wan R; Song R; Fan Y; Li L; Zhang J; Zhang B; Li X; Wang S
Evid Based Complement Alternat Med; 2021; 2021():7604537. PubMed ID: 34457030
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of Xiaoyao San in treatment of depression,breast hyperplasia,and functional dyspepsia based on network pharmacology].
Wei FX; Liu HL; Fan YH; Li XQ; Zhao SJ; Qin XM; Liu XJ
Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4230-4237. PubMed ID: 34467737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
